Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa

被引:33
作者
Gill, Christian M. [1 ]
Lasko, Maxwell J. [1 ]
Asempa, Tomefa E. [1 ]
Nicolau, David P. [1 ,2 ]
机构
[1] Hartford Hosp, Enter Antiinfect Res & Dev, Hartford, CT 06115 USA
[2] Hartford Hosp, Div Infect Dis, Hartford, CT 06115 USA
关键词
Pseudomonas aeruginosa; beta-lactamases; carbapenemase; metallobeta-lactamases; RESISTANCE MECHANISMS; ENTEROBACTERIACEAE;
D O I
10.1128/JCM.02015-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The prevalence of carbapenem-resistant Pseudomonas aeruginosa is increasing. Identification of carbapenemase-producing P. aeruginosa will have therapeutic, epidemiological, and infection control implications. This study evaluated the performance of the EDTA-modified carbapenem inactivation method (eCIM) in tandem with the modified carbapenem inactivation method (mCIM) against a large collection of clinical P. aeruginosa isolates (n = 103) to provide clinicians a phenotypic test that not only identifies carbapenemase production but also distinguishes between metallo-beta-lactamase and serine-carbapenemase production in P. aeruginosa. The mCIM test was performed according to Clinical and Laboratory Standards Institute guidelines, while the eCIM was conducted as previously described for Enterobacteriaceae. Test performance was compared to the genotypic profile as the reference. mCIM testing successfully categorized 91% (112/123) of P. aeruginosa isolates as carbapenemases or non-carbapenemase producers, with discordant isolates being primarily Guiana extended-spectrum (GES)-type producers. To increase the sensitivity of the mCIM for GES-harboring isolates, a double inoculum, prolonged incubation, or both was evaluated, with each modification improving sensitivity to 100% (12/12). Upon eCIM testing, all Verona integrin-encoded metallo-p-lactamases (VIM; n = 27) and New Delhi metallo-beta-lactamases (NDM; n = 13) tested had 100% concordance to their genotypic profiles, whereas all Klebsiella pneumoniae carbapenemase (KPC; n = 8) and GES (n = 12) isolates tested negative, as expected, in the presence of EDTA. The eCIM failed to identify all imipenemase (IMP)-producing (n = 22) and Sao Paulo metallo-beta-lactamase (SPM)-producing (n = 14) isolates. KPC-, VIM-, and NDM-producing P. aeruginosa were well defined by the conventional mCIM and eCIM testing methods; additional modifications appear required to differentiate GES-, IMP-, and SPM-producing isolates.
引用
收藏
页数:7
相关论文
共 24 条
  • [1] Evaluation of the carbapenem inactivation method (CIM) for detecting carbapenemase activity in enterobacteria
    Aguirre-Quinonero, A.
    Cano, M. E.
    Gamal, D.
    Calvo, J.
    Martinez-Martinez, L.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 88 (03) : 214 - 218
  • [2] Asempa TE, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.00535-19, 10.1128/jcm.00535-19]
  • [3] A Plasmid-Encoded Class 1 Integron Contains GES-Type Extended-Spectrum β-Lactamases in Enterobacteriaceae Clinical Isolates in Mexico
    Barrios, Humberto
    Garza-Ramos, Ulises
    Edith Ochoa-Sanchez, Luz
    Reyna-Flores, Fernando
    Rojas-Moreno, Teresa
    Morfin-Otero, Rayo
    Rodriguez-Noriega, Eduardo
    Garza-Gonzalez, Elvira
    Gonzalez, Gloria
    Volkow, Patricia
    Cornejo-Juarez, Patricia
    Silva-Sanchez, Jesus
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 4032 - 4034
  • [4] Carbapenemase-Producing Organisms: A Global Scourge
    Bonomo, Robert A.
    Burd, Eileen M.
    Conly, John
    Limbago, Brandi M.
    Poirel, Laurent
    Segre, Julie A.
    Westblade, Lars F.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (08) : 1290 - 1297
  • [5] Past and Present Perspectives on β-Lactamases
    Bush, Karen
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (10)
  • [6] Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries
    Castanheira, Mariana
    Deshpande, Lalitagauri M.
    Costello, Andrew
    Davies, Todd A.
    Jones, Ronald N.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (07) : 1804 - 1814
  • [7] Clinical Laboratory and Standard Institute, 2019, PERFORMANCE STANDARD, V29
  • [8] Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of β-Lactamases
    Frase, Hilary
    Shi, Qicun
    Testero, Sebastian A.
    Mobashery, Shahriar
    Vakulenko, Sergei B.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (43) : 29509 - 29513
  • [9] Widespread of ESBL- and carbapenemase GES-type genes on carbapenem-resistant Pseudomonas aeruginosa clinical isolates: a multicenter study in Mexican hospitals
    Garza-Ramos, Ulises
    Barrios, Humberto
    Reyna-Flores, Fernando
    Tamayo-Legorreta, Elsa
    Catalan-Najera, Juan C.
    Morfin-Otero, Rayo
    Rodriguez-Noriega, Eduardo
    Volkow, Patricia
    Cornejo-Juarez, Patricia
    Gonzalez, Alejandra
    Gaytan-Martinez, Jesus
    del Rocio Gonzalez-Martinez, Marisela
    Vazquez-Farias, Maria
    Silva-Sanchez, Jesus
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 81 (02) : 135 - 137
  • [10] Epidemiology and Characteristics of Metallo-beta-Lactamase-Producing Pseudomonas aeruginosa
    Hong, Duck Jin
    Bae, Il Kwon
    Jang, In-Ho
    Jeong, Seok Hoon
    Kang, Hyun-Kyung
    Lee, Kyungwon
    [J]. INFECTION AND CHEMOTHERAPY, 2015, 47 (02) : 81 - 97